• Ep 39. UK JIA Biologics Register: stopping biologics for remission

  • Nov 30 2023
  • Duración: 10 m
  • Podcast
Ep 39. UK JIA Biologics Register: stopping biologics for remission  Por  arte de portada

Ep 39. UK JIA Biologics Register: stopping biologics for remission

  • Resumen

  • What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register.

    Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London.

    Managed by the University of Manchester, the UK JIA Biologics Register is a collaboration between BSR and Versus Arthritis that measures the safety and effectiveness of biologic and biosimilar treatment for juvenile idiopathic arthritis.

    Want to find out more? Here's your further reading list:
    1. Read Lianne and Coziana's full paper
    2. Find out more about the UK JIA Biologics Register
    3. Explore research from the BSR biologics registers

    Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Más Menos

Lo que los oyentes dicen sobre Ep 39. UK JIA Biologics Register: stopping biologics for remission

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.